EP1599214A4 - Methods and compositions for treating cervical cancer - Google Patents
Methods and compositions for treating cervical cancerInfo
- Publication number
- EP1599214A4 EP1599214A4 EP04715735A EP04715735A EP1599214A4 EP 1599214 A4 EP1599214 A4 EP 1599214A4 EP 04715735 A EP04715735 A EP 04715735A EP 04715735 A EP04715735 A EP 04715735A EP 1599214 A4 EP1599214 A4 EP 1599214A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- cervical cancer
- treating cervical
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US630590 | 1990-12-20 | ||
US45046403P | 2003-02-27 | 2003-02-27 | |
US450464P | 2003-02-27 | ||
US49009403P | 2003-07-25 | 2003-07-25 | |
US490094P | 2003-07-25 | ||
US10/630,590 US7312041B2 (en) | 2001-02-16 | 2003-07-29 | Methods of diagnosing cervical cancer |
PCT/US2004/006001 WO2004076646A2 (en) | 2003-02-27 | 2004-02-27 | Methods and compositions for treating cervical cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1599214A2 EP1599214A2 (en) | 2005-11-30 |
EP1599214A4 true EP1599214A4 (en) | 2006-06-21 |
Family
ID=32931336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04715735A Withdrawn EP1599214A4 (en) | 2003-02-27 | 2004-02-27 | Methods and compositions for treating cervical cancer |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1599214A4 (en) |
WO (1) | WO2004076646A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6942981B1 (en) | 1999-05-14 | 2005-09-13 | Arbor Vita Corporation | Method of determining interactions with PDZ-domain polypeptides |
WO2010102070A1 (en) * | 2009-03-03 | 2010-09-10 | Arbor Vita Corporation | Methods of treating hpv-associated cancer with jnk inhibitors |
WO2015097268A1 (en) * | 2013-12-23 | 2015-07-02 | Universite De Strasbourg | A chimeric construct for diagnosis and therapy of papillomavirus-induced cancers |
WO2021155518A1 (en) * | 2020-02-05 | 2021-08-12 | Tcrcure Biopharma Corp | Anti-hpv t cell receptors and engineered cells |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003014303A2 (en) * | 2001-08-03 | 2003-02-20 | Arbor Vita Corporation | Molecular interactions in cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4108846A (en) | 1977-02-01 | 1978-08-22 | Hoffmann-La Roche Inc. | Solid phase synthesis with base N alpha-protecting group cleavage |
CA2346965A1 (en) * | 1998-11-17 | 2000-05-25 | Arcaris, Inc. | Methods for validating polypeptide targets that correlate to cellular phenotypes |
-
2004
- 2004-02-27 EP EP04715735A patent/EP1599214A4/en not_active Withdrawn
- 2004-02-27 WO PCT/US2004/006001 patent/WO2004076646A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003014303A2 (en) * | 2001-08-03 | 2003-02-20 | Arbor Vita Corporation | Molecular interactions in cells |
Non-Patent Citations (2)
Title |
---|
See also references of WO2004076646A2 * |
THOMAS MIRANDA ET AL: "Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation", ONCOGENE, vol. 21, no. 33, 1 August 2002 (2002-08-01), pages 5088 - 5096, XP002380805, ISSN: 0950-9232 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004076646A3 (en) | 2005-06-09 |
WO2004076646A2 (en) | 2004-09-10 |
EP1599214A2 (en) | 2005-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2671581B8 (en) | Compositions and methods for treating cancer | |
EP1663259A4 (en) | Compositions and methods for treatment of cancer | |
IL172194A0 (en) | Methods and compositions for treating amyloid-related diseases | |
AU2003284242A8 (en) | Methods and compositions for use in treating cancer | |
GB2423928B (en) | Methods and compositions for treating pain | |
EP1732650A4 (en) | Composition and method for cancer treatment | |
EP1667680A4 (en) | Combination methods of treating cancer | |
EP1468118A4 (en) | Methods and compositions for treating cancer | |
AU2003293194A8 (en) | Compositions and methods for treating prostate cancer | |
IL176919A0 (en) | Methods and compositions for treating cancer | |
AU2003230750A1 (en) | Compositions and methods for treating cancer | |
HK1089676A1 (en) | Formulations and methods for treating rhinosinusitis | |
ZA200600384B (en) | Compositions and methods for increasing bone mineralization | |
GB2421434B (en) | Compositions And Methods For Treating Gynaecological Disorders | |
EP1680073A4 (en) | Compounds and method for treating cancer | |
EP1572118A4 (en) | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
ZA200600025B (en) | Methods and compositions for interferon therapy | |
EP1626711A4 (en) | Compositions and methods for treating cancer | |
PL379264A1 (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
EP1599214A4 (en) | Methods and compositions for treating cervical cancer | |
AU2003225461A8 (en) | Composition and method for supporting cancer treatments | |
EP1587405A4 (en) | Novel compositions and methods for cancer | |
AU2003275433A8 (en) | Compositions and methods for treating pain | |
EP1684795A4 (en) | Methods and agents for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050916 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060524 |
|
17Q | First examination report despatched |
Effective date: 20070718 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100126 |